Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Ceftazidime (2gm) + Avibactam (0.5gm) Injection
Dosage Form : Injection
Packaging Type : Vial
Packaging : 2.5gm
Price : ₹1/-
Dimezeft 2.5 Injection contains a potent combination of Ceftazidime (2gm) and Avibactam (0.5gm). Ceftazidime is a third-generation cephalosporin antibiotic with broad-spectrum activity against many Gram-negative and some Gram-positive bacteria. Avibactam is a non-beta-lactam beta-lactamase inhibitor that protects Ceftazidime from degradation by certain resistant bacteria, thereby significantly enhancing its effectiveness.
This combination is especially effective against multi-drug resistant (MDR) infections, including those caused by extended-spectrum beta-lactamase (ESBL) and carbapenem-resistant strains.
It helps in the treatment of complicated intra-abdominal infections, complicated urinary tract infections (including pyelonephritis), hospital-acquired pneumonia (including ventilator-associated pneumonia), and other life-threatening drug-resistant bacterial infections.
Common side effects may include nausea, vomiting, diarrhea, constipation, headache, and pain at the injection site. Rare but serious effects may include allergic reactions, changes in liver or kidney function, or Clostridium difficile-associated diarrhea.
Indicated for the treatment of serious and drug-resistant bacterial infections, especially in hospital settings. Effective in treating infections of the lungs, abdomen, urinary tract, and bloodstream caused by resistant organisms.
This injection is intended for use only under strict medical supervision, typically in a hospital. Inform your doctor of any known allergies, especially to cephalosporins or penicillins. Dosage adjustments may be needed in patients with renal impairment. Always complete the full course of therapy.
Store below 25°C in a dry place. Protect from direct light. Once reconstituted, use immediately or as per healthcare provider instructions. Keep out of reach of children.
Composition : Calcium Dobesilate Monohydrate I.P. 500 mg Capsule
Composition : L-Arginine (3gm) + Proanthocyanidin (75mg) sachet
Composition : Aminacrine HCl 0.1g + Cetrimide Cream 0.5g
Composition : Chlorhexidine Gluconate (0.20% w/w) + Silver Nitrate (0.20% w/w) cream
Composition : Hydroquinone (2% w/w) + Mometasone (0.1% w/w) + Tretinoin (0.025% w/w)
Composition : Fusidic Acid I.P. 2.00% w/w + Beclomethasone Dipropionate I.P. 0.025% w/w
Composition : Cranberry Extract 300mg + D-Mannose 600mg Tablet
Composition : Ketoconazole (2.0% w/w) + Clobetasol Propionate (0.05% w/w) + Neomycin (0.10% w/w) + Tolnaflate (1.0% w/w) + Iodochlorhydroxy Quinoline (1.0% w/w) Cream
Composition : Terbinafine (1% w/w)
Composition : Tretinoin 0.05% Cream